StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
WNX.L$5.50+0.00%
Fair $5.50+0.0%

WNX.L

Wellnex Life Limited

Consumer Defensive / Packaged FoodsLSE

$5.50

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $5.50Fund rank 22/100 · Data gapFallback financials|
SA 13/F
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 15%

FCF escenarios

weak_data · normalized FCF $-6.9M · quality 31.0/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 12/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

13/100

F

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -2.1%, below the 5% threshold
Thesis & Journal · WNX.LLocal privado en este navegador · Wellnex Life Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-205.2%

↓

Gross Margin

30.0%

↑

Debt/Equity

1.49

↑
52-Week Range$6
$0$16

TradingView lightweight chart

WNX.L price, volumen y niveles de valoración

Último $0.055Periodo -99.8%
Fair value: $5.500

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

+142.0%

FCF CAGR

—

FCF margin

-40.6%

FCF / Net income

0.47x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $16.9M · net income $-14.7M · FCF $-6.9M

2021-FY → 2024-FY

Gross margin

30.0%+43.8% pts

Operating margin

-38.1%+739.0% pts

Net margin

-87.0%+2002.1% pts

FCF margin

-40.6%+397.6% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$16.9M$16.9M$27.9M$18.6M$1.2M
Net Income$-14.7M$-14.7M$-13.8M$-7.4M$-25.0M
EBITDA$-11.6M$-11.6M$-11.9M$-6.3M$-18.7M
EPS-0.78-0.78-1.30-0.85-3.52
Gross Margin30.0%30.0%17.0%24.2%-13.8%
Operating Margin-38.1%-38.1%-25.5%-31.7%-777.1%
Net Margin-87.0%-87.0%-49.7%-40.0%-2089.1%
Balance Sheet
Debt/Equity1.491.4911.701.80-37.38
Current Ratio0.670.67———
Cash Flow
Free Cash Flow$-6.9M$-6.9M$-6.2M$-8.7M$-5.2M
Returns
ROE-205.2%-205.2%-2331.0%-170.9%10026.1%
Valuation
P/B14.3714.37———
Growth & Yield
Revenue Growth-39.3%-39.3%49.8%1457.1%—
EPS Growth39.5%39.5%-52.7%75.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -99.6%

Total return

-99.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-1.30 → -0.78

Residual

-99.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-99.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.